Clicky

Sirnaomics Ltd(2257) News

Date Title
Dec 18 RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770
Dec 5 Sirnaomics Announces Successful Completion of Cohort 1 from Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
Dec 1 Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer